Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses
In 2012, the Norwegian newborn screening program (NBS) was expanded (eNBS) from screening for two diseases to that for 23 diseases (20 inborn errors of metabolism, IEMs) and again in 2018, to include a total of 25 conditions (21 IEMs). Between 1 March 2012 and 29 February 2020, 461,369 newborns were...
Saved in:
Similar Items
-
Newborn Genetic Screening-Still a Role for Sanger Sequencing in the Era of NGS
by: Silje Hogner, et al.
Published: (2023) -
Vitamin B12 Deficiency (Un-)Detected Using Newborn Screening in Norway
by: Trine Tangeraas, et al.
Published: (2023) -
A Retrospective Evaluation of the Predictive Value of Newborn Screening for Vitamin B12 Deficiency in Symptomatic Infants Below 1 Year of Age
by: Ulf Wike Ljungblad, et al.
Published: (2022) -
Misinformation About COVID-19 Vaccines on Social Media: Rapid Review
by: Ingjerd Skafle, et al.
Published: (2022) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020)